Medtrum

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Robo CT Partner Wang Xiaoqi: Winning the International Stage with Manufacturing Excellence

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Pure Global: The International Engine of Medical Technology Globalization

As a pioneer in international regulatory management and clinical solutions, Pure Global has evolved into an indispensable partner for medical technology companies. Through its outstanding data technology, seasoned industry expert team, and transnational capabilities, Pure Global empowers its partners to achieve global growth. Presently, Pure Global's services span more than 25 countries and regions, offering tailored solutions for the entire lifecycle of medical devices.

China's "Top Student" Takes on the "International Exam": United Imaging's Path to Overseas

20 Chinese Companies to Watch in Q1 2023– Healthcare+

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China’s healthcare space in Q1 2023. The following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, the activity level and the segments in which the startups operate.

Pulnovo Medical: Chinese Medical Device Companies are Making Their Voices Heard Globally

‘Chinese medical device companies, represented by Pulnovo Medical, have always pursued medical innovation under the support of policies and capital. They have increasingly improved their technical innovation, strategic planning, and product competitiveness. Navigating the way through a dynamic, ever-changing market, Chinese medical device companies are making their voices heard in the global market.’

Chinese IVD enterprises going global - 10 molecular diagnosis companies to watch

IVD tests are medical devices used to diagnose, monitor, screen and assess predispositions to diseases from assays in a test tube or in a controlled environment outside an organism, contributing to the available medical information of a patient. Molecular diagnosis, as one of the fastest growing segments in IVD, especially during the COVID-19 period, refers to the assessment of a person's health at a molecular level through the detection and measurement of specific genetic si

Chinese Medtech enterprises going global - 10 interventional device makers to watch

The medical devices market continued to generate stellar growth in 2022. With the increasing prevalence of cardiovascular and cerebralvascular disease in China, companies are encouraged to develop and create new innovative solutions. Below, EqualOcean has listed 10 leading interventional medical device companies in vascular or neurology fields with overseas business. We hope this will shed some light on Chinese interventional markets.

Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis

‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’

The Era of Digital Health: Smart Medical Wearable Device as An Important Component

This article introduces smart medical wearable devices in China.

Opportunities and Challenges Hidden in the CGT Industry in China

CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.

China VC Investment List Q4 2022 – Healthcare

For healthcare, we at EqualOcean have identified 20 companies worth watching in Q4 identified by proceedings. We select venture capital investments of over CNY 200 million on average or the equivalent value in USD in a single round.

15 Companies to Watch in December 2022 — Healthcare

Editor's note: We at EqualOcean tracked the major funding rounds and industry events that took place in China's healthcare space in December 2022. And the following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, and the segments in which the companies operate.

2022 China Year-in-Review | Healthcare

2022 has been a tough year for most of the pharmaceutical companies but cold winter will pass eventually. We at EqualOcean presented the 2022 year-in-review in two parts. In the second part, we will list major M&A, product approvals, and strategic collaboration news. It's by no means exhaustive, but it'll shed some light on what's to come

2022 China Year-in-Review | Healthcare

2022 has been a tough year for most of the pharmaceutical companies but cold winter will pass eventually. We at EqualOcean presented the 2022 year-in-review in two parts. In the first part, we will list major financing and IPO news. It's by no means exhaustive, but it'll shed some light on what's to come.

15 Companies to Watch in November 2022-Healthcare

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's healthcare space in November 2022. And the following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, and the segments in which the startups operate.

Challenges and Opportunities Possessed by Digital Therapeutics Industry

Following the digital therapeutics series report, this article is centered on the challenges and opportunities faced by the digital therapeutics industry and aims to provide insights on the two above aspects.

15 Companies to Watch in October 2022-Healthcare

EqualOcean 2022 China AI Health 30 Companies list Reveals

Starting from September 2022, EqualOcean had been conducting deep market research and expert interviews aiming to select out 30 most representative China-based companies in the AI Health sector that are with the most growth and development potential. It is finally officially finalized, and we give our deep and sincere congratulations to those 30 companies and wish them all the best in the future.

Artificial Intelligence and Interventional Surgical Robots

The evolvement and implementation of artificial intelligence (AI) are dramatically changing the medical landscape, and the potential benefits of using AI in interventional medicine are now also being extensively pursued. The article focuses primarily on advances and challenges in AI applied to interventional surgical robots.